Sawadkar Prasad, Lali Ferdinand, Garcia-Gareta Elena, Garrido Beatriz Gil, Chaudhry Abdullah, Matharu Priya, Kyriakidis Christos, Greco Karin
The Griffin Institute - Northwick Park Institute for Medical Research, Northwick Park and St Mark's Hospitals, London, United Kingdom.
Division of Surgery and Interventional Science, University College London, London, United Kingdom.
Front Bioeng Biotechnol. 2025 May 12;13:1454903. doi: 10.3389/fbioe.2025.1454903. eCollection 2025.
Chronic wounds pose a substantial burden on healthcare systems, necessitating innovative tissue engineering strategies to enhance clinical outcomes. Hydrogels, both of natural and synthetic origin, have emerged as versatile biomaterials for wound management due to their structural adaptability, biocompatibility, and tunable physicochemical properties. Their hydrophilic nature enables efficient nutrient transport, waste removal, and cellular integration, while their malleability facilitates application to deep and irregular wounds, providing an optimal microenvironment for cell adhesion, proliferation, and differentiation. Extracellular matrix (ECM)- based hydrogels retain bioactive molecules that support cellular infiltration, immune modulation, and tissue remodelling, making them highly effective scaffolds for growth factor delivery and regenerative therapies. Additionally, their injectability and potential for polymerization enable minimally invasive applications, allowing on-demand gelation at target sites. By modifying their mechanical properties through crosslinking, hydrogels can achieve enhanced structural stability, prolonged degradation control, and improved surgical handling, optimizing their functionality in dynamic wound environments. This review outlines current approaches to skin tissue engineering, examining the biomaterials employed in hydrogel design, their limitations, and their interactions with host tissues. Furthermore, it highlights the emerging potential of functionalized injectable hydrogels, particularly those engineered for controlled drug release, enhanced bioactivity, and patient-specific therapeutic applications. These hydrogels offer a transformative platform for advanced wound care and regenerative medicine.
慢性伤口给医疗系统带来了沉重负担,因此需要创新的组织工程策略来改善临床效果。天然和合成来源的水凝胶因其结构适应性、生物相容性和可调节的物理化学性质,已成为伤口处理中用途广泛的生物材料。它们的亲水性使其能够有效地进行营养物质运输、废物清除和细胞整合,而其可塑性则便于应用于深部和不规则伤口,为细胞黏附、增殖和分化提供最佳微环境。基于细胞外基质(ECM)的水凝胶保留了支持细胞浸润、免疫调节和组织重塑的生物活性分子,使其成为生长因子递送和再生疗法的高效支架。此外,它们的可注射性和聚合潜力允许进行微创应用,能够在目标部位按需凝胶化。通过交联来改变其机械性能,水凝胶可以实现增强的结构稳定性、延长的降解控制和改善的手术操作性能,从而在动态伤口环境中优化其功能。本综述概述了皮肤组织工程的当前方法,研究了水凝胶设计中使用的生物材料、它们的局限性以及它们与宿主组织的相互作用。此外,它强调了功能化可注射水凝胶的新兴潜力,特别是那些设计用于控释药物、增强生物活性和个性化治疗应用的水凝胶。这些水凝胶为先进的伤口护理和再生医学提供了一个变革性平台。